GHK-Cu: Enhancing Hair Follicle Growth Through DHT Inhibition, Anti-Inflammation, and Regeneration

by Dr. James Ross

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

Copper Complexes as Potent DHT Inhibitors

One of the primary drivers of hair loss is dihydrotestosterone (DHT), which is produced in hair follicles by the enzyme 5-alpha reductase (5-AR). There are two main types of this enzyme: type 1, found in hair follicles, and type 2, found in prostate tissue. While oral finasteride (Propecia) mainly inhibits type 2 activity, copper ions are more effective against type 1, the form most damaging to follicle health.

Research by Sugimoto et al. showed that copper (II) ions can inhibit type 1 5-AR by up to 90%, with only minimal effect on type 2. This makes copper-based interventions, such as GHK-Cu, highly specific and potentially more targeted than traditional pharmaceutical options for hair growth.

Anti-Inflammatory and Antioxidant Properties of GHK-Cu

GHK is a naturally occurring tripeptide found in plasma, saliva, and urine. When bound to copper (GHK-Cu), it plays an important role in wound healing, regeneration, and inflammation control.

Studies demonstrate that GHK-Cu reduces inflammatory cytokines such as TNF-α and IL-6 while increasing antioxidant defenses, including superoxide dismutase (SOD). It accomplishes this by modulating NF-κB and p38 MAPK signaling, both of which are central pathways in chronic inflammation.

This dual action—lowering harmful cytokines and reducing oxidative damage—creates a favorable environment for sustaining healthy hair follicle activity.

Remodeling Tissues and Activating Repair Cells

GHK-Cu stimulates a wide range of regenerative processes. It recruits mast cells, macrophages, and capillary cells to sites of repair, while simultaneously enhancing collagen, elastin, VEGF, FGF-2, and nerve growth factor production.

These activities increase fibroblast and keratinocyte proliferation, angiogenesis, and hair follicle size. By expanding follicle-supporting structures and reducing inflammatory stress, GHK-Cu helps sustain robust hair cycling.

Wound Healing and Cell Proliferation Effects

Animal studies show that GHK acts as a powerful chemoattractant, drawing immune and repair cells such as mast cells and leukocytes into damaged areas. This response accelerates wound healing and tissue regeneration.

Further research suggests GHK can regulate microRNAs and signaling pathways that prevent apoptosis and encourage cellular resilience, indirectly supporting follicle survival and function.

Reducing Iron-Induced Oxidative Stress

Iron overload is a major source of oxidative stress and tissue damage, as free iron catalyzes lipid peroxidation and generates reactive oxygen species. GHK-Cu helps by reducing iron release from ferritin by up to 87%, thereby limiting the toxic cascade that damages DNA, proteins, and cell membranes.

Since oxidative damage plays a role in follicle miniaturization and hair loss, this protective mechanism further strengthens GHK-Cu’s role as a hair growth enhancer.

REFERENCES

1. Park JR, Lee H, Kim SI, Yang SR. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016 Sep 6;7(36):58405-58417. doi: 10.18632/oncotarget.11168. PMID: 27517151; PMCID: PMC5295439.
2. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. doi: 10.1163/156856208784909435. PMID: 18644225.
3. Zhang H, Wang Y, He Z. Glycine-Histidine-Lysine (GHK) Alleviates Neuronal Apoptosis Due to Intracerebral Hemorrhage via the miR-339-5p/VEGFA Pathway. Front Neurosci. 2018 Sep 20;12:644. doi: 10.3389/fnins.2018.00644. PMID: 30294253; PMCID: PMC6158323.

Product available for research use only: